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Abstract
Background: Breast cancer is the most commonly diagnosed cancer among U.S. women .The 5-year survival rate
for this tumour is nowadays 85%, and the 61% of these women are still alive at 15 years. When depression
symptoms are present as a consequence of breast cancer treatments, they may interfere negatively with patients’
quality of life. The aim of this study was to examine the effects of breast cancer treatment on the quality of life
and the impact of depression on the health-related life.
Methods: We enrolled 173 women aged 65-75 years with early stage breast cancer diagnosed over the last
10 years, initially recruited to participate in a study examining heath-related quality of life in the first 5 years after
breast cancer diagnosis. Participants were divided into four groups: 1) 46 breast cancer survivors (aged 65-70);
2) 62 women diagnosed with breast cancer (aged 65-69); 3) 32 women with recurrent breast cancer after 10 years
(aged 66-75); 4) 30 women in good health status (aged 60-70). The Geriatric Depression Scale was used as a
routine part of a comprehensive geriatric assessment. Collection of data for the application of instruments, such as
sociodemographic variables (age, educational level, social state) and clinical date (stage and time of the disease
and treatment), was carried out by trained researcher assistants.
Results: Our results demonstrated the correlation between depression and previous cancer experiences. In fact, in
patients with cancer experience, the grade of depression was significantly higher compared to healthy subjects.
Furthermore, we demonstrated that the patients with recurrent breast cancer were severely depressed compared
to other groups.
Conclusions: A high percentage of participants were identified as having emotional and/or well being problems.
Further investigations on the cause of depression problems cancer-related are needed.
Background
Breast cancer is the most commonly diagnosed cancer
among U.S. women [1]. The mean age of all women diag-
nosed with breast cancer is 61 years, and women aged
75-79 years have the highest incidence of the disease [2].
Most encouraging fact is represented by the topic that
women with a history of breast cancer are the largest
group of female cancer survivors. In fact, the 5-year sur-
vival rate is nowadays 85% and 61% of these women are
still alive at 15 years. Approximately 4.4 million women
who were diagnosed with breast cancer in the last 5 year
currently are alive, making breast cancer the single most
prevalent cancer in the world [3]. The term of “breast
cancer survivors” is here used to refer to women with a
history of breast cancer and to emphasize the issues con-
cerning with quality of life in older women disease-free
breast cancer. So, the main issue is the correct under-
standing of the variables that influence quality of life
(QOL) among long-term survivors of breast cancer.
Effective treatments for breast cancer can produce a life
expectancy of 10 or more years, increasing concern for
patients’ QOL [4-7]. When depression symptoms are pre-
sent as a consequence of breast cancer treatments, they
may interfere negatively with patients’ QOL, above all on
QOL of long-term survivors. In addition, when a woman
develops breast cancer all family members may develop
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some sort of illness [8]. It is recognized that breast cancer
diagnosis and its treatment may have a significant practi-
cal and emotional impact on the entire family, but parti-
cularly on partners [9]. The aim of this study was to
examine the effects of breast cancer treatment on the
quality of life and the impact of depression on the health-
related life.
Methods
All eligible patients to participate in this study were
older women with early stage breast cancer diagnosed
over the last 10 years (Table 1). Participants were initi-
ally recruited to participate in a study examining heath-
related quality of life in the first 5 years after breast
cancer diagnosis. The study population was composed of
173 women aged 65-75 years who have been recruited
into the department of geriatrics at Cannizzaro Hospital,
University of Catania. Participants were divided into four
groups: 1) 46 breast cancer survivors (aged 65-70);
2) 62 women diagnosed with breast cancer (aged 65-69);
3) 32 women with recurrent breast cancer after 10 years
(aged 66-75); 4) 30 women in good health status (aged
60-70). Data for the analyses were obtained from 1)
hospital medical records abstracted for the hospitaliza-
tion at the most definitive treatment of breast cancer, 2)
a follow-up survey. The initial consent form signed by all
of the subjects included a statement of willingness to be
contacted about future studies. The Geriatric Depression
Scale (GDS) was used as a routine part of a comprehen-
sive geriatric assessment. The GDS is a measure that is
designed to assess depression in older adults and was
developed and standardized strictly on samples of older
people. The scale consists of a 100 questions about which
selected 30 item self-report assessments designed specifi-
cally to identify depression in elderly. The GDS questions
are answered “yes” or “no”, which is thought to be sim-
pler than scales that use a five-category response set. One
point is assigned to each answer and the cumulative
score is rated on a scoring grid. The grid sets a range of
0-9 as “normal”, 10-19 as “middle depressed”, and 20-30
as “severely depressed”. A score of 10 or 11 or lower is
the usual threshold to separate depressed from non-
depressed patients. Collection of data for the application
of instruments, such as sociodemographic variables (age,
educational level, social state) and clinical date (stage and
time of the disease and treatment), was carried out by
trained researcher assistants. The instruments were sub-
mitted directly by the patients.
Results and discussion
Our results demonstrated the correlation between depres-
sion and previous cancer experiences. In fact, in patients
with cancer experience, the grade of depression was sig-
nificantly higher compared to healthy subjects. Further-
more, we demonstrated that the patients with recurrent
breast cancer were severely depressed compared to the
other study groups. In our study, subjects with breast
cancer and breast cancer survivor showed mild depres-
sion levels. As regards the GDS score, the comparison of
breast cancer survivors and subjects with breast cancer
showed significant group differences (Table 2). This study
evaluated the prevalence of depression symptoms in older
breast cancer survivors. Cancer survivors lose the mean-
ing of health and life itself following a diagnosis of can-
cer. Depression, anxiety, fatigue and sleep disturbance are
among the most commonly reported problems experi-
enced by cancer survivors, above all changes in physical
form and psychosocial modifications. There are several
complications of cancer and its treatment that can cause
or exacerbate an alteration in mood, for example uncon-
trolled pain that can cause anxiety, despair of relief of
their suffering, and at times suicide. In addition, changes
in physical form due to the cancer or its treatment, such
as mastectomy, could have a large impact on the psyche
and contribute to depression mood. Finally, changes in
the life of the person with cancer like being away from
work or not being able to do the usual roles at home
may have affect the person’s self-esteem. As well, the
spiritual side of a person may be severely affected by
their illness. Family members usually provide personal
care and emotional support for the duration of the cancer
experience. Caregivers and family members often require,
but do not receive, the respite, health care, psychosocial,
and financial assistance they need in meeting the many
needs of cancer survivors in their lives. In our study, we
demonstrated that the prevalence of depression was
higher among breast cancer survivors than in breast can-
cer patients.
Table 1 Demographic characteristics of subjects included in the study.
Breast Cancer Survivors Breast Cancer Recurrent breast cancer Healthy subjects
Number 46 62 30 35
Age (years) 69.5 ± 4.7 67.5±5.2 69.8±5.2 68.2±4.2
FC (bpm) 78±3 65±3 80±4 70±4
PAS (mmHg) 138±10 145±8 142±10 144±15
PAD (mmHg) 82±8 85±9 86±6 87±3
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Conclusions
A high percentage of participants were identified as having
emotional and/or well being problems. Moreover the par-
ticipants had a physical activities level that was insufficient
to yield expected benefits. The focus of further researches
should be the investigation of the cause of depression pro-
blems cancer-related and the need for a better under-
standing of why cancer survivors decrease their level of
physical activities following a cancer diagnosis. Increasing
physical activities to a level that is sufficient for cancer sur-
vivors to receive known benefits (for example, reduced
depression, increased functional well being) should be the
goal of any intervention.
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Table 2 Percentage of subjects in each group according to the GDS score.
Breast Cancer survivors Breast cancer Recurrent breast cancer Healthy subjects
Normal 21,7% 51,6% 16,6% 71,42%
Middle depressed 43,4% 32,2% 33,3% 20%
Severely depressed 34,7% 24,19% 50% 8,57%
GDS score: normal 0-9, mild depression 10-19, severe depression 20-30.
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